Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaspian Sunrise Regulatory News (CASP)

  • This share is currently suspended. It was suspended at a price of 1.90

Share Price Information for Caspian Sunrise (CASP)

Share Price is delayed by 15 minutes
Get Live Data
1.90    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £44.77m
CASP Live PriceLast checked at - London Stock Exchange

Intraday Caspian Sunrise Share Chart

US$5 million additional funding from Arawak

18 Jun 2009 14:30

RNS Number : 1359U
Roxi Petroleum Plc
18 June 2009
 



Roxi Petroleum plc 

("Roxi or the "Company")

US$5 million additional funding from Arawak

US$5 million convertible loan from Arawak a subsidiary of the Vitol group 

US$3 million is earmarked to bring Galaz into production

US$2 million will be available for the for general administrative purposes

When taken in conjunction with the recently announced US$24 million GEM facility Roxi has in the past month put in place facilities to provide up to an additional US$29 million of funding

Roxi Petroleum plc ("Roxi" or "the Company"), the Kazakhstan based oil exploration and development company is pleased to announce additional funding from a leading industry participant. 

US$5 million Convertible loan

Roxi is pleased to announce that the Company has entered into an agreement with Arawak Energy Limited ("Arawak"), a subsidiary of the Vitol group, which is one of the world's largest oil traders, to provide a US$5 million loan to Roxi, principally to assist the Company to bring Roxi's Galaz assets into full production.

The loan will carry interest at 7 per cent above LIBOR and is repayable in 12 months at the Company's option. In the event it is not then repaid the loan will, based on today's exchange rate, convert into approximately 31 million Roxi shares at 10p per share.

Approximately US$3 million will be used to develop the Galaz assets to bring them into full production. Approximately US$2 million will be available for general administrative purposes.

In consideration for entering into the loan agreement Roxi will issue Arawak warrants to subscribe for up to 18 million Roxi shares, exercisable before 31  March 2010 at a price of 10p per share, or before 30 September 2010 at 15p per share, or before 31 March 2011 at 20p per share. 

The board believes that the proposed US$5 million convertible loantaken together with funding available under the recently announced US$24 million GEM facility, will provide a far greater level of financial stability that has existed of late and allow the management to focus on the development of the Company's assets. 

Related party transaction

A condition of the loan is that it ranks ahead of loans made by Mr Kuat Oraziman, a director of Roxi. Accordingly, Mr Kuat Oraziman, , has agreed to defer repayment on US$14.5 million existing loans due for repayment in June and July 2009. In return for agreeing to subordinate these loans to Arawak and to extend the repayment dates Roxi has agreed to place US$10 million of his loans on the same commercial terms as negotiated with Arawak. 

Therefore US$10 million of Mr Oraziman's loans will from the date of drawdown under the Arawak loan earn interest at the rate of 7 per cent above LIBOR. Additionally Mr Oraziman will be issued with 36 million warrants exercisable on the same terms as Arawak.

The changes to Mr Oraziman's loans to Roxi constitute related party transactions under the AIM Rules for companies. Roxi's directors, other than Mr Oraziman, after consulting with WH Irelandthe Company's nominated adviser, consider the revised terms of his loans together with the granting of the 36 million warrants fair and reasonable in so far as shareholders are concerned. 

Rob Schoonbrood CEO commented

 "I am delighted that we have been able to secure this substantial new funding - from  top quality partner, with experience in Kazakhstan and who are well aware of the potential of emerging markets oil and gas.

The Arawak funding will, greatly aid our efforts to bring our Galaz asset into production, 

Following a tough year in capital markets, we believe that with this combination of new funding, and a positive outlook operationally, there is every reason for cautious confidence for the future." 

18 June 2009

Enquiries: 

Roxi Petroleum plc

Rob Schoonbrood, CEO +7 727 244 0920

College Hill (Financial PR)

Paddy Blewer / Nick Elwes +44 (0) 20 7457 2020

WH Ireland (NOMAD and broker)

James Joyce +44 (0)20 7220 1666

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWAORKNRNAAR
Date   Source Headline
12th Jan 20237:00 amRNSThird Monthly Dividend Declaration
22nd Dec 20228:14 amRNSOperational Update
5th Dec 20227:00 amRNSSecond Monthly Dividend Declaration
11th Nov 20227:00 amRNSDividend Details
7th Nov 202211:05 amRNSSecond Price Monitoring Extn
7th Nov 202211:00 amRNSPrice Monitoring Extension
4th Nov 20224:40 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 20227:00 amRNSOperational Update and Dividend Declaration
3rd Oct 20224:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:36 pmRNSPrice Monitoring Extension
26th Sep 202210:14 amRNSReplacement Announcement for Interim Results
26th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
11th Aug 20227:00 amRNSResult of GM
30th Jun 20222:21 pmRNSResult of AGM
30th Jun 20228:53 amRNSOraziman family holdings
27th Jun 20227:00 amRNSAnnual Report and Financial Statements
22nd Jun 20228:32 amRNSUK High Court confirms Capital Reduction
6th Jun 20227:00 amRNSOperational and impact of Russian sanctions update
31st May 20227:00 amRNSNotice of AGM
30th May 20227:00 amRNSUK Oil Company Windfall Tax & Dividend Update
25th May 20227:00 amRNSOperational update
22nd Apr 202211:27 amRNSProposed cancellation of share premium account
8th Apr 20229:05 amRNSSecond Price Monitoring Extn
8th Apr 20229:00 amRNSPrice Monitoring Extension
7th Apr 20223:17 pmRNSReview of Q1 2022
5th Apr 20227:00 amRNSProposed cancellation of share premium account
9th Mar 20222:12 pmRNSDebt Conversion and Operational Updates
15th Feb 20227:00 amRNSProposed Debt Conversion and General Meeting
25th Jan 20227:48 amRNSDeep Well Production at BNG
19th Jan 202211:36 amRNSHolding(s) in Company
19th Jan 202211:31 amRNSHolding(s) in Company
19th Jan 202211:26 amRNSHolding(s) in Company
19th Jan 202211:24 amRNSHolding(s) in Company
10th Jan 20224:27 pmRNSGrant of options
10th Jan 20227:46 amRNSOperational update
6th Jan 202212:19 pmRNSOperational update
23rd Dec 20218:35 amRNSOperational update
22nd Dec 20217:00 amRNSOperational, financial and shareholding update
13th Oct 20217:00 amRNSBNG operational update
21st Sep 20217:00 amRNSInterim Results
18th Aug 202112:03 pmRNSTotal Voting Rights
6th Aug 20217:00 amRNSStrategic, Financial, Operational Update
27th Jul 20211:11 pmRNSCompany’s first horizontal well is successful
23rd Jul 202112:06 pmRNSAGM Voting
29th Jun 20217:00 amRNSAnnual Report and Financial Statements
3rd Jun 20217:00 amRNSOperational Update
13th May 20217:00 amRNSShare issue
16th Apr 20217:00 amRNSIncrease in price for oil sold to domestic market
8th Apr 202110:27 amRNSBNG Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.